Last reviewed · How we verify

NCT06292338

Lung Sonar in Neonatal Respiratory Disorders

Status unknown Last updated 5 March 2024
What this trial tests

trial in Neonatal Respiratory Distress in 1 participant. Status unknown.

Timeline
1 May 2024
Primary endpoint
1 May 2025
1 May 2025

Quick facts

Lead sponsorGehad Adel Mohammed Hussein
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1
Start date1 May 2024
Primary completion1 May 2025
Estimated completion1 May 2025

Conditions studied

Sponsor

Gehad Adel Mohammed Hussein

Who can join

Adults 1 Day to 28 Days, any sex, with Neonatal Respiratory Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to determine the value of chest ultrasonography in comparison to other tools as chest x-ray and ABG in diagnosis and follow up of neonates with respiratory disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neonatal Respiratory Distress

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06292338.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing